Search
Now showing items 1-10 of 63
Is Burning Mouth Syndrome Based on a Physiological Mechanism which Resembles that of Neuropathic Pain?
(Facultad de Odontología. Universidad de Costa Rica, 2020)
Neurosteroids and neuropathic pain: an up-to-date perspective
(Elsevier, 2022-02)
This perspective aims to broaden our view on the role of neurosteroids, especially progesterone, allopregnanolone, and dehydroepiandrosterone, in the regulation of neuropathic pain. We will make special emphasis on new ...
Persistent Idiopathic Dentoalveolar pain. Literature review and clinical case treated with intraoral application of Botulinum toxin
(Facultad de Odontología. Universidad de Costa Rica, 2021)
El uso de toxina botulínica en el tratamiento de la neuralgia del trigémino (V par craneal)
(Facultad de Odontología. Universidad de Costa Rica, 2018)
Progesterone modulates pro-inflammatory cytokine expression profile after spinal cord injury: implications for neuropathic pain
(Elsevier Inc, 2016-03-15)
Neuropathic pain is a frequent complication of spinal cord injury (SCI), still refractory to conventional treatment. Glial cell activation and cytokine production contribute to the pathology of central neuropathic syndromes. ...
(E)-3-Furan-2-yl- N- p-tolyl-acrylamide and its Derivative DM489 Decrease Neuropathic Pain in Mice Predominantly by α7 Nicotinic Acetylcholine Receptor Potentiation
(American Chemical Society, 2020-10-19)
The main objective of this study was to determine whether (E)-3-furan-2-yl-N-p-tolyl-acrylamide (PAM-2) and its structural derivative DM489 produce anti-neuropathic pain activity using the streptozotocin (STZ)- and ...
Phenotypes and diagnosis in neuropathic painFenotipos y diagnóstico en dolor neuropático
(Sociedad Española Multidisciplinaria del Dolor, 2021)
Although all the clinical pictures of peripheral neuropathic pain have a common denominator as a characteristic, that is; damage or disease of the somatosensory nervous system, we must estimate that the underlying etiologies ...
The Use of Botulinum Toxin in the Treatment of Trigeminal Neuralgia (Fifth Cranial Nerve)
(Universidad de Costa Rica, 2018)
A3 receptor agonist modulates IL-1β hippocampus levels in a rat model of neuropathic pain
(HCPA/FAMED/UFRGS, 2022)